江西生物：董事會會議通告

HKEXAug 17 16:33 · Announcements

Jiangxi Biological (06915) Executive Director Jing Ruihua purchased an additional 1.128 million shares over three days, increasing his stake to 0.37%.

According to equity disclosure data from the Hong Kong Stock Exchange, Jing Ruihua, Executive Director of Jiangxi Bio (06915), purchased additional shares of the company on July 27, July 28, and July 29, for three consecutive trading days, amounting to a total of 1.128 million shares.

Zhitong FinanceJul 30 20:08

ZHITONG HK Shareholder Equity Disclosure | July 30

HKEX Shareholder Equity Disclosure | July 30

Zhitong FinanceJul 30 08:05

Jiangxi Biology (06915.HK) received an increase of 644,500 H-shares from Jing Ruihua, valued at approximately HK$87.008 million.

As reported on July 29, according to documents disclosed by the Hong Kong Stock Exchange (HKEX) on July 29, Jing Ruihua purchased an additional 644,500 H-shares of Jiangxi Bioscience (06915.HK) on July 27 at an average price of HK$13.5 per share, amounting to approximately HK$8.7008 million. Following this acquisition, Jing Ruihua’s latest holding stands at 644,500 shares, increasing their beneficial ownership stake from 0.00% to 0.21%. Source: HKEX Equity Ownership Disclosure What is equity ownership disclosure? Under HKEX requirements, substantial shareholders—individuals or companies holding 5% or more of a listed company’s shares—must disclose their shareholdings in the listed company.

Futu NewsJul 29 17:08

Jiangxi Biological (06915.HK) received an increase of 412,500 H-shares from Jing Ruihua, valued at approximately HK$6.3641 million.

According to a filing disclosed by the Hong Kong Stock Exchange on July 29, Jing Ruihua acquired 412,500 H shares of Jiangxi Bioscience (06915.HK) on July 28 at an average price of HK$15.428 per share, amounting to approximately HK$6.3641 million. Following this acquisition, Jing Ruihua’s total holding increased to 1,057,000 shares, raising his beneficial ownership stake from 0.21% to 0.34%. Source: HKEX Equity Disclosure What is equity disclosure? Under the requirements of the Hong Kong Stock Exchange, substantial shareholders (individuals or companies holding 5% or more) must disclose their shareholdings in listed companies. Listed

Futu NewsJul 29 17:08

Jiangxi Biological (06915.HK) received an increase of 71,000 H-shares from Jing Ruihua, valued at approximately HK$1.171 million.

As reported on July 29, according to a filing disclosed by the Hong Kong Stock Exchange on July 29, Jing Ruihua acquired 71,000 H-shares of Jiangxi Bioscience (06915.HK) on July 29 at an average price of HK$16.493 per share, amounting to approximately HK$1.171 million. Following this purchase, Jing Ruihua’s total holding increased to 1,128,000 shares, raising their beneficial ownership stake from 0.34% to 0.37%. Source: Shareholding Disclosure, Hong Kong Stock Exchange What is shareholding disclosure? Under the requirements of the Hong Kong Stock Exchange, substantial shareholders—individuals or companies holding 5% or more of a listed company’s shares—must disclose their interests in the company’s shares. Listed companies

Futu NewsJul 29 17:08